EXAS

$0.00

(

+0.00%

)
Quote details

stock

EXACT Sciences Corporation

NASDAQ | EXAS

67.50

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 11, 2025)

$12.61B

Market Cap

-

P/E Ratio

-5.35

EPS

$72.81

52 Week High

$38.81

52 Week Low

HEALTHCARE

Sector

EXAS Chart

Recent Chart
Price Action

EXAS Technicals

Tags:

EXAS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.9B
Total Revenue $2.8B
Cost Of Revenue $840M
Costof Goods And Services Sold $840M
Operating Income -$1B
Selling General And Administrative $1.4B
Research And Development $431M
Operating Expenses $3B
Investment Income Net -
Net Interest Income -$37M
Interest Income -
Interest Expense $32M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $215M
Income Before Tax -$1B
Income Tax Expense -$7.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$1B
Comprehensive Income Net Of Tax -
Ebit -$1B
Ebitda -$789M
Net Income -$1B

Revenue & Profitability

Earnings Performance

EXAS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $5.9B
Total Current Assets $1.6B
Cash And Cash Equivalents At Carrying Value $601M
Cash And Short Term Investments $601M
Inventory $162M
Current Net Receivables $249M
Total Non Current Assets $4.4B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1B
Intangible Assets Excluding Goodwill $1B
Goodwill $2.4B
Investments -
Long Term Investments -
Short Term Investments $437M
Other Current Assets $122M
Other Non Current Assets -
Total Liabilities $3.5B
Total Current Liabilities $732M
Current Accounts Payable $90M
Deferred Revenue -
Current Debt -
Short Term Debt $277M
Total Non Current Liabilities $2.8B
Capital Lease Obligations $185M
Long Term Debt $2.3B
Current Long Term Debt $249M
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.8B
Other Current Liabilities $366M
Other Non Current Liabilities $316M
Total Shareholder Equity $2.4B
Treasury Stock -
Retained Earnings -$4.5B
Common Stock $1.9M
Common Stock Shares Outstanding $184M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $211M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $215M
Capital Expenditures $136M
Change In Receivables -
Change In Inventory -$35M
Profit Loss -
Cashflow From Investment -$442M
Cashflow From Financing $232M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $31M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$1B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.9B
Total Revenue $2.8B
Cost Of Revenue $840M
Costof Goods And Services Sold $840M
Operating Income -$1B
Selling General And Administrative $1.4B
Research And Development $431M
Operating Expenses $3B
Investment Income Net -
Net Interest Income -$37M
Interest Income -
Interest Expense $32M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $215M
Income Before Tax -$1B
Income Tax Expense -$7.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$1B
Comprehensive Income Net Of Tax -
Ebit -$1B
Ebitda -$789M
Net Income -$1B

EXAS News

EXAS Profile

EXACT Sciences Corporation Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Exact Sciences Corporation is a pioneering company in cancer diagnostics, dedicated to enhancing early detection and treatment outcomes through its innovative screening and diagnostic tests. Based in Madison, Wisconsin, the firm is best known for its flagship Cologuard test, which significantly advances the early detection of colorectal cancer. With a commitment to transforming cancer care, Exact Sciences harnesses state-of-the-art technology and robust research initiatives to drive growth and expand its market presence, solidifying its status as a formidable entity in the healthcare landscape.

MSPR
+75.64%
$0.55
ASBP
-24.64%
$0.11
NVDA
-2.95%
$193.16
PLUG
-1.17%
$2.53
PFE
+4.59%
$25.51
YDKG
-18.51%
$0.02
ACHR
+5.79%
$8.94
ASST
-8.10%
$1.36
RIVN
+9.81%
$18.02
VHAI
0.00%
$0.00
F
+1.10%
$13.30
BYND
-8.95%
$1.22
ONDS
-1.36%
$5.80
INTC
+0.83%
$38.45
CRWV
-16.30%
$88.39
AXDX
-61.36%
$0.03
GRAB
-0.33%
$5.88
DNN
+3.52%
$2.64
SOFI
+1.34%
$30.95
WTO
-15.20%
$0.03
TSLA
-1.26%
$439.62
AMD
-2.64%
$237.52
NIO
-2.18%
$6.71
BITF
-5.86%
$3.37
TWOH
+10.41%
$0.00
RIG
+0.71%
$4.23
WULF
-13.49%
$12.37
RGTI
-5.07%
$31.40
ADAP
-15.14%
$0.05
SNAP
+0.80%
$8.76
PLTR
-1.36%
$190.96
MARA
-6.09%
$14.63
AAPL
+2.16%
$275.25
XPEV
+7.81%
$28.07
NBIS
-7.03%
$102.22
ETHD
+7.26%
$4.43
CHR
-13.75%
$0.04
AAL
-2.40%
$12.99
T
+1.47%
$25.19
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
DVLT
-11.65%
$1.44
CMG
-2.19%
$29.81
QS
-2.27%
$15.91
BBD
+3.04%
$3.72
SRM
+53.27%
$10.30
NOK
-1.00%
$6.90
NVTS
-5.00%
$9.12
CIFR
-4.98%
$18.67
JOBY
+3.67%
$16.35
BTBT
-2.96%
$2.95
QBTS
-1.29%
$28.99
TURB
-12.44%
$2.18
VCIG
-26.55%
$1.30
LFS
+576.78%
$11.37
SOUN
-6.73%
$13.44
TLRY
-1.52%
$1.29
IREN
-4.63%
$57.38
BURU
-6.33%
$0.25
PBR
+3.49%
$13.46
KVUE
-0.29%
$16.72
LYFT
+1.93%
$24.18
HPE
-4.14%
$22.89
WLGS
-5.57%
$0.04
KLTR
+25.17%
$1.84
NVO
+6.98%
$49.15
BTG
+0.48%
$4.11
IOVA
+11.81%
$2.65
QUBT
-6.81%
$11.83
NGD
+2.38%
$7.30
RXRX
+4.43%
$4.71
BTE
+3.28%
$2.67
HBAN
+0.06%
$15.82
CORZ
-10.21%
$17.32
PLTZ
+2.83%
$5.81
AGNC
+0.58%
$10.31
RF
+0.76%
$25.04
AMZN
+0.28%
$249.10
AFMD
-34.94%
$0.18
IONZ
+2.98%
$4.14
RKLB
+0.50%
$51.90
VALE
+0.32%
$12.34
EOSE
-3.49%
$18.52
HIMS
-3.16%
$39.75
ITUB
+2.62%
$7.83
APLD
-9.12%
$28.57
MU
-4.81%
$241.11
GPUS
-3.42%
$0.34
VZ
-0.44%
$39.85
REAL
+38.09%
$15.48
CAN
-3.47%
$1.11
RIOT
-6.81%
$16.14
BMNR
-3.79%
$39.59
BAC
+0.39%
$53.63
CGC
-5.90%
$1.19
SMCI
-3.40%
$38.82
PLTD
+1.45%
$6.27
ABEV
+3.89%
$2.53
PCG
+0.24%
$16.60
CSCO
-0.52%
$71.71
MSPR
+75.64%
$0.55
ASBP
-24.64%
$0.11
NVDA
-2.95%
$193.16
PLUG
-1.17%
$2.53
PFE
+4.59%
$25.51
YDKG
-18.51%
$0.02
ACHR
+5.79%
$8.94
ASST
-8.10%
$1.36
RIVN
+9.81%
$18.02
VHAI
0.00%
$0.00
F
+1.10%
$13.30
BYND
-8.95%
$1.22
ONDS
-1.36%
$5.80
INTC
+0.83%
$38.45
CRWV
-16.30%
$88.39
AXDX
-61.36%
$0.03
GRAB
-0.33%
$5.88
DNN
+3.52%
$2.64
SOFI
+1.34%
$30.95
WTO
-15.20%
$0.03
TSLA
-1.26%
$439.62
AMD
-2.64%
$237.52
NIO
-2.18%
$6.71
BITF
-5.86%
$3.37
TWOH
+10.41%
$0.00
RIG
+0.71%
$4.23
WULF
-13.49%
$12.37
RGTI
-5.07%
$31.40
ADAP
-15.14%
$0.05
SNAP
+0.80%
$8.76
PLTR
-1.36%
$190.96
MARA
-6.09%
$14.63
AAPL
+2.16%
$275.25
XPEV
+7.81%
$28.07
NBIS
-7.03%
$102.22
ETHD
+7.26%
$4.43
CHR
-13.75%
$0.04
AAL
-2.40%
$12.99
T
+1.47%
$25.19
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
DVLT
-11.65%
$1.44
CMG
-2.19%
$29.81
QS
-2.27%
$15.91
BBD
+3.04%
$3.72
SRM
+53.27%
$10.30
NOK
-1.00%
$6.90
NVTS
-5.00%
$9.12
CIFR
-4.98%
$18.67
JOBY
+3.67%
$16.35
BTBT
-2.96%
$2.95
QBTS
-1.29%
$28.99
TURB
-12.44%
$2.18
VCIG
-26.55%
$1.30
LFS
+576.78%
$11.37
SOUN
-6.73%
$13.44
TLRY
-1.52%
$1.29
IREN
-4.63%
$57.38
BURU
-6.33%
$0.25
PBR
+3.49%
$13.46
KVUE
-0.29%
$16.72
LYFT
+1.93%
$24.18
HPE
-4.14%
$22.89
WLGS
-5.57%
$0.04
KLTR
+25.17%
$1.84
NVO
+6.98%
$49.15
BTG
+0.48%
$4.11
IOVA
+11.81%
$2.65
QUBT
-6.81%
$11.83
NGD
+2.38%
$7.30
RXRX
+4.43%
$4.71
BTE
+3.28%
$2.67
HBAN
+0.06%
$15.82
CORZ
-10.21%
$17.32
PLTZ
+2.83%
$5.81
AGNC
+0.58%
$10.31
RF
+0.76%
$25.04
AMZN
+0.28%
$249.10
AFMD
-34.94%
$0.18
IONZ
+2.98%
$4.14
RKLB
+0.50%
$51.90
VALE
+0.32%
$12.34
EOSE
-3.49%
$18.52
HIMS
-3.16%
$39.75
ITUB
+2.62%
$7.83
APLD
-9.12%
$28.57
MU
-4.81%
$241.11
GPUS
-3.42%
$0.34
VZ
-0.44%
$39.85
REAL
+38.09%
$15.48
CAN
-3.47%
$1.11
RIOT
-6.81%
$16.14
BMNR
-3.79%
$39.59
BAC
+0.39%
$53.63
CGC
-5.90%
$1.19
SMCI
-3.40%
$38.82
PLTD
+1.45%
$6.27
ABEV
+3.89%
$2.53
PCG
+0.24%
$16.60
CSCO
-0.52%
$71.71

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.